AÇÃO AUTÓCRINA DA OCITOCINA EM CARDIOMIÓCITOS: DUPLA ESTIMULAÇÃO DA SECREÇÃO DE ANP E INIBIÇÃO DEPENDENTE DE ÓXIDO NÍTRICO
DOI:
https://doi.org/10.56238/arev7n8-304Palavras-chave:
Ocitocina, Peptídeo Natriurético Atrial, Óxido Nítrico, CardiomiócitosResumo
Historicamente conhecida por suas ações sobre o sistema reprodutor, hoje se sabe que a ocitocina (OT) também pode contribuir para a regulação da homeostase cardiovascular e hidroeletrolítica. A OT é produzida nos núcleos supra-óptico e paraventricular do hipotálamo e liberada para o plasma a partir de terminais neurais da pituitária posterior, no entanto, muitos estudos identificaram locais extra-cerebrais de produção OT, incluindo o coração e o endotélio vascular. A ativação de seus receptores em células endoteliais, bem como em sistemas hipotalâmicos/hipofisários e cardíaco, pode resultar na produção de óxido nítrico (NO). O presente trabalho teve como objetivo verificar o papel do NO na regulação da secreção de peptídeo natriurético atrial (ANP) estimulada por OT em cultura primária de cardiomiócitos de embriões de camundongos. Para tal, corações de embriões de camundongos Balb C, com 19 a 21 dias de vida intra-uterina, foram isolados e cultivados para os ensaios com OT e demais substâncias interferentes na síntese de NO e GMPc seu segundo mensageiro. A adição de concentrações crescentes de OT (0.1, 1, 10 e 100 µM) induziu aumento proporcional na secreção de ANP e nitrato para o meio, confirmando a ação estimuladora da OT em cardiomiócitos. O bloqueio da liberação de ANP estimulada por OT (10 µM) foi observada após adição de Ornitina Vasotocina (CVI-OVT) (100 µM), um antagonista específico de OT. Este antagonista inibiu a secreção basal de ANP, quando adicionado individualmente, sugerindo que a OT pode atuar via mecanismo autócrino, tônico estimulatório sobre a secreção de ANP. Amplificação da secreção de ANP estimulada por OT (10 µM) foi observada após sua associação com L-NAME, um inibidor da sintase de óxido nítrico (NOS) (600 µM), e ODQ (100 µM), um inibidor da guanilato ciclase solúvel, sugerindo a ocorrência de feedback negativo nitrérgico na liberação de ANP estimulada por OT no cardiomiócito. Os resultados obtidos mostraram modulação nitrérgica inibidora sobre a secreção de ANP estimulada por OT.
Downloads
Referências
ANTUNES-RODRIGUES, J., CASTRO, M., ELIAS, L.L.K., VALENÇA, M.M., McCANN, S. M. Neuroendocrine control of body fluid metabolism. Physiological Reviews, v.84, p.169-208, 2004. DOI: https://doi.org/10.1152/physrev.00017.2003
BALLIGAND, J. L., CANNON, P. J. Nitric oxide synthases and cardiac muscle autocrine and paracrine influences. Arterioscler Thromb Vasc Biol., v. 7, p. 1846-58, 1997. DOI: https://doi.org/10.1161/01.ATV.17.10.1846
BALLIGAND, J.L., KOBZIK, L., HAN, X., KAYE, D.M., BELHASSEN, L., O’HARA, D.S., KELLY, R.A., SMITH, T.W., MICHEL, T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem., v. 270, n. 24, p. 14582-14586, 1995.
BALLIGAND, J.L., KOBZIK, L., HAN, X., KAYE, D.M., BELHASSEN, L., O’HARA, D.S. , et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem; v. 270, p. 14582-6, 1995. DOI: https://doi.org/10.1074/jbc.270.24.14582
BALLIGAND, J.L. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J. Mol. Cell Cardiol., v. 30, n. 2, p. 303-315, 1998. DOI: https://doi.org/10.1006/jmcc.1997.0593
BAROUCH, L.A., HARRISON, R.W., SKAF, M.W., ROSAS, G.O., CAPPOLA, T.P., KOBEISSI, Z. A., HOBAI, I.A., LEMMON, C.A., BURNETT, A.L., O’ROURKE, B., RODRIGUEZ, E.R., HUANG, P.L., LIMA, J.A., BERKOWITZ, D.E., HARE, J.M. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature., v. 416, p. 337–339, 2002. DOI: https://doi.org/10.1038/416337a
BUSSE, R., FLEMING, I. Nitric Oxide and Regulation of Vascular Tone. In: MAYER, B., (Ed.). Nitric Oxide. Berlin: Springer, p. 179-206, 2000. DOI: https://doi.org/10.1007/978-3-642-57077-3_9
CAMPBELL, D. L.; STAMLER, J. S.; STRAUSS, H. C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J. Gen. Physiol, v. 108, n. 4, p. 277-293, 1996. DOI: https://doi.org/10.1085/jgp.108.4.277
CLEMENTI, E., VECCHIO, I., SCIORATI, C., NISTICÒ, G. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I. Mol. Pharmacol., v. 47, n. 3, p. 517-524, 1995. DOI: https://doi.org/10.1016/S0026-895X(25)08558-X
FAVARETTO, A.L.V., BALLEJO, G.O., ALBUQUERQUE-ARAÚJO, W.I.C., GUTKOWSKA, J., ANTUNES-RODRIGUES, J., MCCANN, S.M. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides, v.18, n.9, .1377-1381, 1997. DOI: https://doi.org/10.1016/S0196-9781(97)00209-X
GIMPL, G., FAHRENHOLZ, F. The oxytocin receptor system: structure, function and regulation. Physiological Reviews, v.81, n.2, p.629-683, 2001. DOI: https://doi.org/10.1152/physrev.2001.81.2.629
GUTKOWSKA J, JANKOWSKI M. Oxytocin revisited: Its role in cardiovascular regulation. Journal of Neuroendocrinology., v. 24, p.559-608, 2012. DOI: https://doi.org/10.1111/j.1365-2826.2011.02235.x
GUTKOWSKA, J., JANKOWSKI, M., MUKADDAM-DAHER, S., MCCAN, S.M. Oxytocin is a cardiovascular hormone. Brazilian Journal of Medical and Biological Research, v.33, p.625-633, 2000. DOI: https://doi.org/10.1590/S0100-879X2000000600003
JIN, J.Y., WEN, J.F., LI, D., CHO, K.W. Osmoregulation of atrial myocytic ANP release: osmotransduction via cross-talk between L-type Ca2+ channel and SR Ca2+ release. Am J. Physiol Regul. Integr. Comp. Physiol., v. 287, p. R1101- R1109, 2004. DOI: https://doi.org/10.1152/ajpregu.00063.2004
HAANWINCKEL, M.A., ELIAS, L.K., FAVARETTO, A.L.V., GUTKOWSKA, J., McCANN, S.M., ANTUNES-RODRIGUES, J. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proceedings of the National Academy of Science, v.92, p.7902-7906, 1995. DOI: https://doi.org/10.1073/pnas.92.17.7902
HAMPL, V., WALTERS, C. L., ARCHER, S. L. Determination of nitric oxide by the chemiluminescence reaction with ozone. In: Feelisch, M. Stamler, J. S. (Eds). Methods in Nitric Oxide Research. Wiley, New York, p.309-318, 1996.
HAN, X., KUBOTA, I., FERON, O., OPEL, D. J., ARSTALL, M.A., ZHAO, Y.Y., HUANG, P., FISHMAN, M.C., MICHEL, T., KELLY, R. A. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA., v. 95, p. 6510-6515, 1998. DOI: https://doi.org/10.1073/pnas.95.11.6510
HARTZELL, H. C., FISCHMEISTER, R. Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells. Nature, v. 323, n. 6085, p. 273-275, 1986. DOI: https://doi.org/10.1038/323273a0
HIRATA, M. KOHSE, K. P., CHANG, C.H., IKEBE, T., MURAD, F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem., v. 265, n. 3, p. 1268-1273, 1990. DOI: https://doi.org/10.1016/S0021-9258(19)40008-2
JANKOWSKI, M., HAJJAR, F., KAWAS, S.A., MUKADDAM-DAHER, S., HOFFMAN, G., MCCANN, S.M., GUTKOWSKA, J. Rat heart: a site of oxytocin production and action. Proceedings of the National Academy of Science, v.95, p.14558-14563, 1998. DOI: https://doi.org/10.1073/pnas.95.24.14558
KADEKARO, M., SUMMY-LONG, J.Y., HARRIS, J.S., TERRELL, M.L., FREEMAN, S., EISENBERG; H. M. Cerebral metabolic responses and vasopressin and oxytocin secretion during progressive deprivation in rats. Am. J. Physiol., v.262, p. 310-317, 1992. DOI: https://doi.org/10.1152/ajpregu.1992.262.2.R310
KARCZEWSKI, P., HENDRISCHKE, T., WOLF, W.P., MORANO, I., BARTEL, S., SCHRADER, J. Phosphorylation of phospholamban correlates with relaxation of coronary artery induced by nitric oxide, adenosine, and prostacyclin in the pig. J. Cell Biochem., v. 70, n. 1, p. 49-59, 1998. DOI: https://doi.org/10.1002/(SICI)1097-4644(19980701)70:1<49::AID-JCB6>3.0.CO;2-3
KOMALAVILAS, P., LINCOLN, T. M. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J. Biol. Chem., v. 271, n. 36, p. 21933-21938, 1996. DOI: https://doi.org/10.1074/jbc.271.36.21933
LESKINEN, H., VUOLTEENAHO, O., LEPPALUOTO, J. AND RUSKOAHO, H. Role of nitric oxide on cardiac hormone secretion: Effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology., v.136, n. 3, p.1241-1249, 1995. DOI: https://doi.org/10.1210/endo.136.3.7867578
MACHADO, F.S., MARTINS, G.A., ALIBERTI, J.C., MESTRINER, F.L., CUNHA, F.Q., SILVA, J. S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation., v. 102, p. 3003-3008, 2000. DOI: https://doi.org/10.1161/01.CIR.102.24.3003
MASSION, P.B., FERON, O., DESSY, C., BALLIGAND, J.L. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res., v. 93, n. 5, p. 388-398, 2003. DOI: https://doi.org/10.1161/01.RES.0000088351.58510.21
MERY, P. F., LOHMANN, S.M., WALTER, U., FISCHMEISTER, R. Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A., v. 88, n. 4, p. 1197- 1201, 1991. DOI: https://doi.org/10.1073/pnas.88.4.1197
MUKADDAM-DAHER, S., YIN, Y.L., ROY, J., GUTKOWSKA, J., CARDINAL, R. Negative inotropic and chronotropic effects of oxytocin. Hypertension., v.38, p.292-296, 2001. DOI: https://doi.org/10.1161/01.HYP.38.2.292
PATON, J.F., KASPAROV, S., PATERSON, D. J. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci., v. 25, p. 626–631, 2002. DOI: https://doi.org/10.1016/S0166-2236(02)02261-0
PETERSSON, M. Cardiovascular effects of oxytocin. Prog Brain Res.,v.139, p. 281-288, 2002. DOI: https://doi.org/10.1016/S0079-6123(02)39024-1
REBSAMEN, M.C., CHURCH, D.J., MORABITO, D., VALLOTTON, M.B., LANG, U. Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes. Am J Physiol., v. 273, p. E922-E931, 1997 DOI: https://doi.org/10.1152/ajpendo.1997.273.5.E922
SANDER, M., CHAVOSHAN, B., VICTOR, R.G. A large blood pressure raising effect of nitric oxide synthase inhibition in humans. Hypertension., v. 33, p. 937-942. 1999. DOI: https://doi.org/10.1161/01.HYP.33.4.937
SEARS, C. E.; ASHLEY, E. A.; CASADEI, B. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philosophical Transactions Royal Society of London, London, v.359: p.1021-1044, 2004. DOI: https://doi.org/10.1098/rstb.2004.1477
SHAH, A. M. et al. 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ. Res., v. 74, n. 5, p. 970-978, 1994. DOI: https://doi.org/10.1161/01.RES.74.5.970
SOARES, T.J., COIMBRA, T.M., MARTINS, A.R., PEREIRA, A.G.F., CARNIO, E.C., BRANCO, L.G.S., ALBUQUERQUE-ARAUJO, W.I.C., NUCCI, G., FAVARETTO, A.L.V., GUTKOWSKA, J., McCAN, S.M., ANTUNES-RODRIGUES, J. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proceedings of the National Academy of Science, v.96, p.278-283, 1999. DOI: https://doi.org/10.1073/pnas.96.1.278
SOUALMIA, H., BARTHELEMY, C., EURIN, J., MASSON, F., CARAYON, A. Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue. Regul Pept., v. 98, p. 105-110. 2001. DOI: https://doi.org/10.1016/S0167-0115(00)00237-8
TOHSE, N., NAKAYA H, TAKEDA Y, KANNO, M. Cyclic GMP-mediated inhibition of L-type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J. Pharmacol, v. 114, p. 1076-1082, 1995. DOI: https://doi.org/10.1111/j.1476-5381.1995.tb13316.x
YASUDA, S. LEW, W. Y. Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes. Circ. Res., v. 81, n. 6, p. 1011-1020, 1997. DOI: https://doi.org/10.1161/01.RES.81.6.1011
WAHLER, G. M., DOLLINGER, S. J. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol., v. 268, n. 1 Pt 1, p. C45-C54, 1995 DOI: https://doi.org/10.1152/ajpcell.1995.268.1.C45
ZIOLO, M.T., KATOH, H., BERS, D. M. Expression of inducible nitric oxide synthase depresses ß- adrenergic–stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation., v. 104, p. 2961–2966, 2001. DOI: https://doi.org/10.1161/hc4901.100379
